Published online December 1, 2005
PEDIATRICS Vol. 116 No. 6 December 2005, pp. 1287-1291 (doi:10.1542/10.1542/peds.2004-2718)

This Article Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services E-mail this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Add to My File Cabinet Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Web of Science (7) Citing Articles via Google Scholar Google Scholar Articles by Yeung, L. F. Articles by Seward, J. F. Search for Related Content PubMed PubMed Citation Articles by Yeung, L. F. Articles by Seward, J. F. Related Collections Musculoskeletal System Related AAP Red Book topics: Measles Social Bookmarking                         What's this?

A Limited Measles Outbreak in a Highly Vaccinated US Boarding School

Lorraine F. Yeung, MD, MPH^*,, Perrianne Lurie, MD, MPH, Gustavo Dayan, MD^||, Eduard Eduardo, MPH^¶, Phyllis H. Britz, RN, Susan B. Redd^||, Mark J. Papania, MD, MPH^|| and Jane F. Seward, MBBS, MPH^||

^* Epidemic Intelligence Service, Epidemiology Program Office
Division of Birth Defects and Developmental Disabilities, National Center on Birth Defects and Developmental Disabilities
^|| Viral Vaccine-Preventable Diseases Branch, Epidemiology & Surveillance Division, National Immunization Program, Centers for Disease Control and Prevention, Atlanta, Georgia
Pennsylvania Department of Health, Harrisburg, Pennsylvania
^¶ Columbia University, New York, New York

Objectives. We investigated a measles outbreak that began in March 2003 in a Pennsylvania boarding school with >600 students to identify all cases, including the source; implement outbreak control measures; and evaluate vaccine effectiveness.

Methods. Measles was suspected in any person at the school with a generalized rash and fever during March 21 to May 28, 2003 and investigated with serologic testing. We reviewed vaccination history from school records and conducted a survey to determine country of measles vaccination. Vaccine effectiveness was calculated using the cohort method.

Results. We identified 9 laboratory-confirmed cases at the school: 8 students and 1 staff member. Among them, 2 had never received any doses of measles-containing vaccine (MCV), 1 received 1 dose of MCV, and 6 received 2 doses of MCV. Three of the 6 who received 2 doses of MCV received both doses outside the United States. The source case had been infected in Lebanon. Two laboratory-confirmed spread cases were identified in New York City. Measles virus of genotype D4 was isolated in cases from the school and New York City. Of the 663 students in the school, 8 (1.2%) had never received any doses of MCV, 26 (3.9%) had received 1 dose, and 629 (94.9%) had received 2 doses before the outbreak. Vaccine effectiveness among students who had received 2 doses of MCV was 98.6%. However, students who received both doses outside the United States had a higher attack rate (3 of 75) than those who received both doses in the United States (3 of 509; rate ratio: 6.8; 95% confidence interval: 1.4–33.0).

Conclusions. This is the largest measles outbreak to occur in a school in the United States since 1998, but it was limited to only 9 cases in a boarding school with >600 students. The limited extent of this outbreak highlights the high level of population immunity achieved in the United States through widespread implementation of a 2-dose measles-mumps-rubella vaccination strategy in school-aged children. States and schools should continue to enforce strictly the 2-dose measles-mumps-rubella vaccination requirement and, in an outbreak setting, consider revaccinating students who received measles vaccine outside of the United States. Continued vigilance by health care providers is needed to recognize measles cases.

---

Key Words: measles • measles-mumps-rubella vaccine • vaccines • disease outbreaks • immunizations • school • school-aged children

Abbreviations: MCV, measles-containing vaccine • MMR, measles-mumps-rubella • PADOH, Pennsylvania Department of Health • IgM, immunoglobulin M • IgG, immunoglobulin G • VE, vaccine effectiveness • CI, confidence interval

---

Accepted Mar 1, 2005.

CiteULike    Connotea    Del.icio.us    Digg    Facebook    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				S. Doshi, N. Khetsuriani, K. Zakhashvili, L. Baidoshvili, P. Imnadze, and A. Uzicanin Ongoing measles and rubella transmission in Georgia, 2004-05: implications for the national and regional elimination efforts Int. J. Epidemiol., February 1, 2009; 38(1): 182 - 191. [Abstract] [Full Text] [PDF]

				D. B. Fishbein, K. R. Broder, L. Markowitz, and N. Messonnier New, and Some Not-so-New, Vaccines for Adolescents and Diseases They Prevent Pediatrics, January 1, 2008; 121(Supplement_1): S5 - S14. [Abstract] [Full Text] [PDF]

				S. K. Raut, P. S. Kulkarni, M. A. Phadke, S. S. Jadhav, S. V. Kapre, R. M. Dhere, S. P. Dhorje, and S. R. Godse Persistence of Antibodies Induced by Measles-Mumps-Rubella Vaccine in Children in India Clin. Vaccine Immunol., October 1, 2007; 14(10): 1370 - 1371. [Abstract] [Full Text] [PDF]

				C. W. LeBaron, J. Beeler, B. J. Sullivan, B. Forghani, D. Bi, C. Beck, S. Audet, and P. Gargiullo Persistence of Measles Antibodies After 2 Doses of Measles Vaccine in a Postelimination Environment Arch Pediatr Adolesc Med, March 1, 2007; 161(3): 294 - 301. [Abstract] [Full Text] [PDF]

				C. T. D'Angio, P. A. Boohene, A. Mowrer, S. Audet, M. A. Menegus, D. S. Schmid, and J. A. Beeler Measles-Mumps-Rubella and Varicella Vaccine Responses in Extremely Preterm Infants Pediatrics, March 1, 2007; 119(3): e574 - e579. [Abstract] [Full Text] [PDF]